Par Drugs And Chemicals Limited

PAR

Quarterly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 202627

    Quarter₹ croreYoY
    Sept 202435+33.9%
    Dec 202421-10.9%
    Mar 202522-2.1%
    Jun 202526+15.2%
    Sept 202529-17.3%
    Dec 202529+37.2%
    Mar 202620-12.2%
    Jun 202631+20.1%
    Sept 202627-4.3%
  • ₹ crore

    Sept 2026<0.01

    Quarter₹ crore
    Sept 20241
    Dec 20240.27
    Mar 20250.79
    Jun 20252
    Sept 20250.48
    Dec 20251
    Mar 20260.36
    Jun 20260.94
    Sept 2026<0.01
  • ₹ crore

    Sept 202627

    Quarter₹ crore
    Sept 202436
    Dec 202422
    Mar 202523
    Jun 202528
    Sept 202529
    Dec 202531
    Mar 202620
    Jun 202632
    Sept 202627
  • Cost structure
  • ₹ crore

    Sept 20261

    Quarter₹ crore
    Sept 20241
    Dec 20241
    Mar 20252
    Jun 20251
    Sept 20251
    Dec 20251
    Mar 20262
    Jun 20262
    Sept 20261
  • ₹ crore

    Sept 202624

    Quarter₹ crore
    Sept 202424
    Dec 202421
    Mar 202521
    Jun 202523
    Sept 202524
    Dec 202524
    Mar 202619
    Jun 202626
    Sept 202624
  • Exceptional items and tax
  • ₹ crore

    Sept 20264

    Quarter₹ crore
    Sept 202411
    Dec 20240.77
    Mar 20252
    Jun 20254
    Sept 20256
    Dec 20256
    Mar 20260.83
    Jun 20266
    Sept 20264
  • ₹ crore

    Sept 20260.92

    Quarter₹ crore
    Sept 20243
    Dec 20240.19
    Mar 20250.63
    Jun 20251
    Sept 20251
    Dec 20252
    Mar 2026-0.02
    Jun 20262
    Sept 20260.92
  • Profit
  • ₹ crore

    Sept 20263

    Quarter₹ croreYoY
    Sept 20249+75.7%
    Dec 20240.58-83.1%
    Mar 20252-55.6%
    Jun 20253+31.4%
    Sept 20254-52.0%
    Dec 20255+730.0%
    Mar 20260.85-48.3%
    Jun 20265+41.6%
    Sept 20263-36.4%
  • Per share
  • ₹ per share

    Sept 20262.14

    Quarter₹ per share
    Sept 20246.99
    Dec 20240.47
    Mar 20251.34
    Jun 20252.70
    Sept 20253.36
    Dec 20253.90
    Mar 20260.69
    Jun 20263.83
    Sept 20262.14
  • Leverage
  • Debt to equity

    times

    Dec 20250.00x

    Quartertimes
    Sept 20240.00x
    Dec 2024—
    Mar 20250.00x
    Jun 20250.00x
    Sept 2025—
    Dec 20250.00x
    Mar 2026—
    Jun 2026—
    Sept 2026—
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
352122262929203127
Revenue YoY+33.9%-10.9%-2.1%+15.2%-17.3%+37.2%-12.2%+20.1%-4.3%
10.270.7920.4810.360.94<0.01
362223282931203227
Cost structure
112111221
242121232424192624
Exceptional items and tax
110.7724660.8364
30.190.63112-0.0220.92
Profit
90.5823450.8553
Net profit YoY+75.7%-83.1%-55.6%+31.4%-52.0%+730.0%-48.3%+41.6%-36.4%
Per share
6.990.471.342.703.363.900.693.832.14
Leverage
Debt to equity0.00x—0.00x0.00x—0.00x———

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.